General Information

Mainterm3,9-BIS(2,4-BIS(1-METHYL-1-PHENYLETHYL)PHENOXY)-2,4,8,10-TETRAOXA-3,9-DIPHOPHASPIRO(5,5)UNDECANE
CAS Reg.No.(or other ID)154862-43-8
Regnum 178.2010

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID164499
IUPAC Name3,9-bis[2,4-bis(2-phenylpropan-2-yl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
InChIInChI=1S/C53H58O6P2/c1-49(2,39-21-13-9-14-22-39)43-29-31-47(45(33-43)51(5,6)41-25-17-11-18-26-41)58-60-54-35-53(36-55-60)37-56-61(57-38-53)59-48-32-30-44(50(3,4)40-23-15-10-16-24-40)34-46(48)52(7,8)42-27-19-12-20-28-42/h9-34H,35-38H2,1-8H3
InChI KeyWBWXVCMXGYSMQA-UHFFFAOYSA-N
Canonical SMILESCC(C)(C1=CC=CC=C1)C2=CC(=C(C=C2)OP3OCC4(CO3)COP(OC4)OC5=C(C=C(C=C5)C(C)(C)C6=CC=CC=C6)C(C)(C)C7=CC=CC=C7)C(C)(C)C8=CC=CC=C8
Molecular FormulaC53H58O6P2

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight852.989
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count12
Complexity1240.0
CACTVS Substructure Key Fingerprint A A A D c f B 8 O A M A A A A A A A A A A A A A A A A A A A A A A A A 0 a M G D A A A A A A A B V A A A G g A A A C A A D g S g m A I y B o A A A R C A A i B C A A A C A A A g I A A I i A A G C I g I J i K A E R K A M A A l w B E I i A e A w P A P o A A C A A A I A A B A A A Q A A B A A A A A A A A A A A A = =
Topological Polar Surface Area55.4
Monoisotopic Mass852.371
Exact Mass852.371
XLogP3None
XLogP3-AA14.4
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count61
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9323
Human Intestinal AbsorptionHIA+0.9685
Caco-2 PermeabilityCaco2+0.6092
P-glycoprotein SubstrateSubstrate0.5000
P-glycoprotein InhibitorInhibitor0.8203
Non-inhibitor0.8613
Renal Organic Cation TransporterNon-inhibitor0.8295
Distribution
Subcellular localizationMitochondria0.7126
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8235
CYP450 2D6 SubstrateNon-substrate0.7819
CYP450 3A4 SubstrateSubstrate0.6076
CYP450 1A2 InhibitorNon-inhibitor0.5432
CYP450 2C9 InhibitorNon-inhibitor0.6744
CYP450 2D6 InhibitorNon-inhibitor0.8939
CYP450 2C19 InhibitorInhibitor0.5347
CYP450 3A4 InhibitorNon-inhibitor0.6861
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.7277
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.6618
Non-inhibitor0.8552
AMES ToxicityNon AMES toxic0.9133
CarcinogensNon-carcinogens0.7475
Fish ToxicityHigh FHMT0.7552
Tetrahymena Pyriformis ToxicityHigh TPT0.9573
Honey Bee ToxicityHigh HBT0.8715
BiodegradationNot ready biodegradable0.9219
Acute Oral ToxicityIV0.6298
Carcinogenicity (Three-class)Non-required0.5984

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-4.3254LogS
Caco-2 Permeability1.0302LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.0662LD50, mol/kg
Fish Toxicity0.4272pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.7944pIGC50, ug/L

From admetSAR


Taxonomic Classification

KingdomOrganic compounds
SuperclassPhenylpropanoids and polyketides
ClassDiarylheptanoids
SubclassLinear diarylheptanoids
Intermediate Tree NodesNot available
Direct ParentLinear diarylheptanoids
Alternative Parents
Molecular FrameworkAromatic heteropolycyclic compounds
SubstituentsLinear 1,7-diphenylheptane skeleton - Diphenylmethane - Phenylpropane - Phenoxy compound - Benzenoid - Monocyclic benzene moiety - Organic phosphite - Oxacycle - Organoheterocyclic compound - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as linear diarylheptanoids. These are diarylheptanoids with an open heptane chain. The two aromatic rings are linked only by the heptane chain.

From ClassyFire